Evidence map›Paper›PMID 28633864›Full record

ReviewTrends in microbiology2017

Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.

Jay Vornhagen, Kristina M Adams Waldorf, Lakshmi Rajagopal

Abstract readReview
In one paragraph

Review in Trends in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 162 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. mBio · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Microbiota-dependent IFN-L controls uterine and placental immunity.bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. A murine model of adult gastrointestinal colonization by Group BbioRxiv : the preprint server for biology · 2025
    Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Jay VornhagenDepartment of Global Health, University of Washington, Seattle, WA, USA; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Kristina M Adams WaldorfDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA; Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
Lakshmi RajagopalDepartment of Global Health, University of Washington, Seattle, WA, USA; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA. Electronic address: lakshmi.rajagopal@seattlechildrens.org.
University of Washington · USUniversity of Gothenburg · SE

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
GBS mediated in utero fetal injuryR01AI100989 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2012 to 2016
$3.9M
Role of an ornithine rhamnolipid pigment in GBS virulenceR01AI112619 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2014 to 2018
$2.4M
Role of human cervical mucus plugs in ascending GBS infectionR21AI125907 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2016 to 2017
$538k
NIAID NIH HHS R01 AI100989NIAID NIH HHS R01 AI112619NIAID NIH HHS R21 AI125907NIAID NIH HHS T32 AI007509NIH HHS P51 OD010425
6 · The paper itself

Abstract

Group B streptococcus (GBS) or Streptococcus agalactiae is a β-hemolytic, Gram-positive bacterium that is a leading cause of neonatal infections. GBS commonly colonizes the lower gastrointestinal and genital tracts and, during pregnancy, neonates are at risk of infection. Although intrapartum antibiotic prophylaxis during labor and delivery has decreased the incidence of early-onset neonatal infection, these measures do not prevent ascending infection that can occur earlier in pregnancy leading to preterm births, stillbirths, or late-onset neonatal infections. Prevention of GBS infection in pregnancy is complex and is likely influenced by multiple factors, including pathogenicity, host factors, vaginal microbiome, false-negative screening, and/or changes in antibiotic resistance. A deeper understanding of the mechanisms of GBS infections during pregnancy will facilitate the development of novel therapeutics and vaccines. Here, we summarize and discuss important advancements in our understanding of GBS vaginal colonization, ascending infection, and preterm birth.

Indexed as

Antibiotic ProphylaxisAnimalsFemaleHumansMicePregnancyPregnancy Complications, InfectiousStreptococcal InfectionsStreptococcal VaccinesStreptococcus agalactiaeVirulence FactorsStreptococcal VaccinesVirulence Factorsascending infectionGroup B streptococcusperinatalpreterm birthvaginal colonization infection

Identifiers

PMID28633864
PMCPMC5650539
OpenAlexW2626807591

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.